Dorling Janet
- SEC CIK
- 0001738144
No open-market purchases or sales filed in the past year.
Current role at each company
- CBAY CymaBay Therapeutics, Inc.Directoras of Mar 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dorling Janet as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 (view filing) | Feb 12 | 2 days | Dorling JanetDirector | SSale | −6.00K | $31.97 | −$191.8K | −100.0%0 after | 10b5-1 |
| Jan 10, 2024 (view filing) | Jan 10 | Same day | Dorling JanetDirector | SSale | −6.00K | $23.86 | −$143.2K | −100.0%0 after | 10b5-1 |
| Dec 11, 2023 (view filing) | Dec 11 | Same day | Dorling JanetDirector | SSale | −6.00K | $20.07 | −$120.4K | −100.0%0 after | 10b5-1 |
| Nov 14, 2023 (view filing) | Nov 10 | 4 days | Dorling JanetDirector | SSale | −7.00K | $15.24 | −$106.7K | −100.0%0 after | 10b5-1 |